Analyze Diet
Equine veterinary journal2012; 45(1); 56-59; doi: 10.1111/j.2042-3306.2012.00554.x

Elimination half-life of intravenously administered equine cardiac troponin I in healthy ponies.

Abstract: To date, no information is available on the true biological elimination half-life (T(1/2) ) of cardiac troponin I (cTnI) in the equine species. Such data are required to better evaluate the optimal time to acquire the cTnI sample following acute myocardial injury. Objective: To determine the T(1/2) of equine cTnI. Methods: Four healthy ponies received i.v. injections of recombinant equine cTnI. Plasma cTnI concentrations were measured with a point-of-care cTnI analyser at multiple time points after injection. Standard pharmacokinetic analysis was performed to establish the T(1/2) of cTnI. Results: The average T(1/2) of cTnI was determined to be 0.47 h using a single rate elimination model. Conclusions: The elimination of recombinant equine cTnI following i.v. administration is very rapid. Establishing the T(1/2 ) of troponin provides critical information in understanding the clinical application of this cardiac biomarker in equine practice.
Publication Date: 2012-03-20 PubMed ID: 22432543DOI: 10.1111/j.2042-3306.2012.00554.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explored how quickly a specific protein, cardiac troponin I (cTnI), is eliminated from the bodies of horses. It found that this protein’s half-life is approximately 0.47 hours, indicating that it leaves a horse’s body fairly quickly after being introduced.

Objective and Methodology

  • The research sought to determine the biological elimination half-life (T(1/2) ) of equine cTnI. Half-life is the time required for the concentration of a substance in the body to decrease by half. Information regarding the half-life of cTnI in horses is necessary to identify optimal times for sampling after an acute myocardial injury—like a heart attack.
  • To conduct the study, researchers administered intravenous (i.v.) injections of recombinant equine cTnI to four healthy ponies.
  • cTnI concentrations in the ponies’ plasma were measured at multiple time points following the injection and were analyzed using standard pharmacokinetic analysis practices to ascertain the half-life of cTnI.

Results

  • The average elimination half-life of cTnI was found to be 0.47 hours using a single rate elimination model. This rapid speed suggests that cTnI is eliminated quickly from a horse’s body following intravenous administration. The half-life of a substance can be influenced by several factors, such as the body’s metabolism rate, the substance’s solubility, the body’s state of hydration, and more.

Conclusions

  • The basis of this study is significant as the half-life of cTnI provides vital insight into how this cardiac biomarker might be used in equine practice. Understanding these parameters can help veterinarians better make diagnoses or take actions based on cTnI measurements.
  • The researchers concluded that the elimination of recombinant equine cTnI following i.v. administration in ponies is very rapid. This information is useful for clinical applications involving this cardiac biomarker in real-world equine treatment scenarios.

Cite This Article

APA
Kraus MS, Kaufer BB, Damiani A, Osterrieder N, Rishniw M, Schwark W, Gelzer AR, Divers TJ. (2012). Elimination half-life of intravenously administered equine cardiac troponin I in healthy ponies. Equine Vet J, 45(1), 56-59. https://doi.org/10.1111/j.2042-3306.2012.00554.x

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 45
Issue: 1
Pages: 56-59

Researcher Affiliations

Kraus, M S
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, New York, NY, USA. msk16@cornell.edu
Kaufer, B B
    Damiani, A
      Osterrieder, N
        Rishniw, M
          Schwark, W
            Gelzer, A R
              Divers, T J

                MeSH Terms

                • Animals
                • Cloning, Molecular
                • Female
                • Half-Life
                • Horses / blood
                • Horses / metabolism
                • Male
                • Recombinant Proteins
                • Troponin I / administration & dosage
                • Troponin I / blood
                • Troponin I / pharmacokinetics

                Citations

                This article has been cited 5 times.
                1. Henrik Kristensen J, Amalie Wistisen Koczulab C, Anton Frandsen E, Bo Hasselbalch R, Strandkjær N, Jørgensen N, Østergaard M, Hasse Møller-Sørensen P, Christian Nilsson J, Afzal S, Rørbæk Kamstrup P, Dahl M, Bor MV, Frikke-Schmidt R, Rye Jørgensen N, Rode L, Holmvang L, Kjærgaard J, Evi Bang L, Forman J, Dalhoff K, Bundgaard H, Karmark Iversen K. Kinetics of cardiac troponin and other biomarkers in patients with ST elevation myocardial infarction.. Int J Cardiol Heart Vasc 2023 Oct;48:101250.
                  doi: 10.1016/j.ijcha.2023.101250pubmed: 37602285google scholar: lookup
                2. Gunther-Harrington CT, Arthur R, Estell K, Martinez Lopez B, Sinnott A, Ontiveros E, Varga A, Stern JA. Prospective pre- and post-race evaluation of biochemical, electrophysiologic, and echocardiographic indices in 30 racing thoroughbred horses that received furosemide.. BMC Vet Res 2018 Jan 18;14(1):18.
                  doi: 10.1186/s12917-018-1336-0pubmed: 29347921google scholar: lookup
                3. Shields E, Seiden-Long I, Massie S, Leguillette R. 24-Hour Kinetics of Cardiac Troponin-T Using a "High-Sensitivity" Assay in Thoroughbred Chuckwagon Racing Geldings after Race and Associated Clinical Sampling Guidelines.. J Vet Intern Med 2018 Jan;32(1):433-440.
                  doi: 10.1111/jvim.14870pubmed: 29171090google scholar: lookup
                4. Bijsmans ES, Jepson RE, Wheeler C, Syme HM, Elliott J. Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.. J Vet Intern Med 2017 May;31(3):650-660.
                  doi: 10.1111/jvim.14655pubmed: 28387019google scholar: lookup
                5. Luethy D, Slack J, Kraus MS, Gelzer AR, Habecker P, Johnson AL. Third-Degree Atrioventricular Block and Collapse Associated with Eosinophilic Myocarditis in a Horse.. J Vet Intern Med 2017 May;31(3):884-889.
                  doi: 10.1111/jvim.14682pubmed: 28295606google scholar: lookup